Cell News and Research

RSS

Scientists identify the first genetic mechanism that generates the cerebral cortex

The cerebral cortex, the largest and most complex component of the brain, is unique to mammals and alone has evolved human specializations. Although at first all stem cells in charge of building the cerebral cortex-the outermost layer of neurons commonly referred to as gray matter-are created equal, soon they irrevocably commit to forming specific cortical regions. But how the stem cells' destiny is determined has remained an open question.

14 Oct 2009

Vanda Pharmaceuticals announces its agreement with Novartis Pharma AG

Vanda Pharmaceuticals Inc. announced today that it has entered into an agreement with Novartis Pharma AG to commercialize and develop Fanapt(TM) (iloperidone), Vanda's anti-psychotic, in the U.S. and Canada. Fanapt(TM) was approved by the U.S. Food and Drug Administration on May 6, 2009 for the acute treatment of schizophrenia in adults.

14 Oct 2009

Positive results from Metabolex' Phase 1 MBX-2982 clinical trial for treating type 2 diabetes

Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced positive results from two multiple ascending dose Phase 1 clinical trials of MBX-2982.

14 Oct 2009

Case Western Reserve University researchers step up to National Institutes of Health challenge

Futuristic plans to grow replacement organs, bones or muscles for soldiers maimed on the battlefield or patients suffering from debilitating disease or injury won't be anything but science fiction unless new blood vessels can grow into that tissue

14 Oct 2009

NIH awards Gladstone Institute consortium $3.7M for Huntington's disease research

The National Institutes of Health (NIH) has awarded a "Grand Opportunity" grant of $3.7 million to a consortium formed with the Gladstone Institute of Neurological Disease (GIND) and the Taube-Koret Center for Huntington's Disease Research to use stem cell technology to better understand Huntington's disease (HD) and to develop potential therapies.

14 Oct 2009

Bioluminescence imaging distinguishes tumor growth in vivo; leads to early treatment of eye cancer

At the moment, doctors rely on biopsy analysis to determine the progression of eye cancer. However, researchers now believe that a new technology, bioluminescence imaging (BLI), will allow doctors to detect tumors earlier and quickly choose a method of treatment that doesn't necessarily involve eye surgery.

14 Oct 2009

Sequella receives Phase 1 SBIR grant for developing SQ641

Sequella, Inc., a clinical-stage biopharmaceutical company focused on commercializing novel antibiotics to treat life-threatening infectious diseases, today announced that it received a $594,661 two-year Small Business Innovative Research (SBIR) grant from the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) for the development of SQ641, Sequella's lead compound in its capuramycin series, a new class of antibiotic.

13 Oct 2009

Sixth annual Medical Student Research Forum highlights latest findings

Members of Qatar's research and medical community recently gathered at Weill Cornell Medical College in Qatar to learn more about research conducted by the college's pre-medical and medical students.

13 Oct 2009

The Automation Partnership's ambr technology to be previewed at the Bioprocess International Conference

The Automation Partnership (TAP), a world leader in the design and development of innovative automation for life science applications, is exclusively previewing its Advanced Microscale BioReactor (ambr™) technology on Booth 914 at the Bioprocess International Conference in Raleigh, USA.

13 Oct 2009

SAFC Pharma expands contract manufacturing services

SAFC Pharma®, a business segment of SAFC®, a member of the Sigma-Aldrich® Group, today announced the completion of an addition to its Carlsbad, Calif., facility that expands the Company's contract manufacturing services for its late phase and commercial clients.

13 Oct 2009

$SAFC Pharma's Pharmorphix Solid State Research Laboratories installs new single crystal X-ray diffraction system$

SAFC Pharma's Pharmorphix Solid State Research Laboratories installs new single crystal X-ray diffraction system

SAFC Pharma®, a business segment of SAFC®, a member of the Sigma-Aldrich® Group, today announced that its Pharmorphix® Solid State Research Laboratories in Cambridge, UK, have installed a new single crystal X-ray diffraction system. The Oxford Diffraction SuperNova(TM) system, which can determine the crystal structures from the most challenging crystal samples, is the first industrial installation of this state-of-the-art instrumentation anywhere in the world.

13 Oct 2009

NIH funds the University of California's consortium for immune disorder research

The University of California, San Francisco has been designated to lead a new consortium that will study a group of severe immune disorders known as primary immunodeficiencies and aims to improve treatment for these often life-threatening diseases. The Primary Immune Deficiency Treatment Consortium comprises 13 centers throughout the United States and has a $6.25 million funding commitment over five years from the National Institutes of Health.

13 Oct 2009

Phyton Biotech purchases NPI’s assets

Phyton Biotech, LLC (Phyton), an affiliate of Phyton, Inc., today announced that it has purchased the assets of Natural Pharmaceuticals, Inc. (NPI), a leading manufacturer of oncology drug active pharmaceutical ingredients (API’s).

13 Oct 2009

Mechanism by which gene associated with autism and schizophrenia influences behavior identified

A Stanford University School of Medicine researcher has pinpointed the mechanism by which a gene associated with both autism and schizophrenia influences behavior in mice. And just recently, he received a $1.65 million government grant to expand his efforts to include many more such genes.

13 Oct 2009

Histostem awarded U.S. patent for isolation of mesenchymal stem cells

Stem Cell Therapy International, Inc. announced that its soon to be subsidiary, Histostem Ltd. of South Korea ("Histostem"), has been awarded U.S. Patent Number 7,582,477 B2, entitled "Method of Isolating and Culturing Mesenchymal Stem Cell Derived from Cryopreserved Umbilical Cord Blood." This patented method is utilized across the company for research, clinical and cosmetic applications.

13 Oct 2009

Surgeons perform groundbreaking procedure using patient's own stem cells for repairing bone deficiencies

In a first-of-its kind procedure, physicians have used stem cells taken from the fat tissue of a 14-year-old boy and combined them with growth protein and donor tissue to grow viable cheek bones in the teen.

13 Oct 2009

European Patent Office announces intention to grant patent for Phyton Biotech's methods of producing taxanes

Phyton Biotech GmbH, a world leader in plant cell culture technology, reports that the European Patent Office has announced its intention to grant a European patent to Phyton covering methods of producing taxanes such as paclitaxel.

13 Oct 2009

Public lecture at UC Riverside to focus on the evolutionary struggle for cancer

Cancer is a leading cause of death worldwide. Our evolutionary struggle with this disease is the focus of a free, public lecture at UC Riverside.

13 Oct 2009

Study demonstrates coexistence of visuospatial and phonological disorders in dyslexics

Chinese-speaking children with dyslexia have a disorder that is distinctly different, and perhaps more complicated and severe, than that of English speakers. Those differences can be seen in the brain and in the performance of Chinese children on visual and oral language tasks, reveals a report published online on October 12th in Current Biology, a Cell Press publication.

13 Oct 2009

Researchers identify genes that play a role in the development of endometrial cancer

Researchers at the University of Gothenburg, Sweden, have identified two genes believed to play a role in the development of endometrial cancer. These results may eventually lead to better diagnosis and treatment of this increasingly common form of cancer.

12 Oct 2009

Cell News and Research

Scientists identify the first genetic mechanism that generates the cerebral cortex

Vanda Pharmaceuticals announces its agreement with Novartis Pharma AG

Positive results from Metabolex' Phase 1 MBX-2982 clinical trial for treating type 2 diabetes

Case Western Reserve University researchers step up to National Institutes of Health challenge

NIH awards Gladstone Institute consortium $3.7M for Huntington's disease research

Bioluminescence imaging distinguishes tumor growth in vivo; leads to early treatment of eye cancer

Sequella receives Phase 1 SBIR grant for developing SQ641

Sixth annual Medical Student Research Forum highlights latest findings

The Automation Partnership's ambr technology to be previewed at the Bioprocess International Conference

SAFC Pharma expands contract manufacturing services

SAFC Pharma's Pharmorphix Solid State Research Laboratories installs new single crystal X-ray diffraction system

NIH funds the University of California's consortium for immune disorder research

Phyton Biotech purchases NPI’s assets

Mechanism by which gene associated with autism and schizophrenia influences behavior identified

Histostem awarded U.S. patent for isolation of mesenchymal stem cells

Surgeons perform groundbreaking procedure using patient's own stem cells for repairing bone deficiencies

European Patent Office announces intention to grant patent for Phyton Biotech's methods of producing taxanes

Public lecture at UC Riverside to focus on the evolutionary struggle for cancer

Study demonstrates coexistence of visuospatial and phonological disorders in dyslexics

Researchers identify genes that play a role in the development of endometrial cancer

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News